The sales forecast of modulators of the genital system and sex hormones in Italy, measured in US Dollars PPP per capita, is steady from 2024 to 2028. It remains constant at 2.5 from 2025 onward, following a slight decrease from 2.6 in 2024. Compared to 2023's metrics, 2024 shows no increase, implying a stagnation in growth. The year-on-year percentage change from 2024 to 2028 is effectively zero, predicting stability without significant variation. This suggests a plateau in the market, as indicated by a zero CAGR over the period.

Future trends to watch for include:

Potential impacts of new medical advancements on market demand.
Social and demographic changes influencing contraceptive use.
Regulatory changes affecting the availability or prescription dynamics of these hormones.
Evolving public perception and acceptance of hormone-related therapies.